Health Care & Life Sciences » Pharmaceuticals | Zenith Health Care Ltd.

Zenith Health Care Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
32,705.00
36,320.70
34,652.20
48,221.00
95,124.00
Cost of Goods Sold (COGS) incl. D&A
29,993.40
34,407.10
32,061.60
42,220.20
66,880.00
Gross Income
2,711.60
1,913.70
2,590.70
6,000.70
28,244.00
SG&A Expense
7,201.40
5,353.30
7,831.30
7,595.80
25,458.00
EBIT
4,982.00
4,003.50
5,890.40
2,123.80
2,786.00
Unusual Expense
-
5.80
6.10
-
4.00
Non Operating Income/Expense
375.80
131.60
732.50
142.60
1,286.00
Interest Expense
21.90
55.60
76.90
60.50
73.00
Pretax Income
4,030.10
3,516.90
4,770.60
1,721.30
4,003.00
Income Tax
1,326.80
1,099.50
1,665.00
199.90
836.00
Consolidated Net Income
2,703.40
2,417.40
3,105.70
1,521.40
3,167.00
Net Income
2,703.40
2,417.40
3,105.70
1,521.40
3,167.00
Net Income After Extraordinaries
2,703.40
2,417.40
3,105.70
1,521.40
3,167.00
Net Income Available to Common
2,703.40
2,417.40
3,105.70
1,521.40
3,167.00
EPS (Basic)
0.05
0.04
0.06
0.03
0.09
Basic Shares Outstanding
53,739.00
53,739.00
53,739.00
53,739.00
-
EPS (Diluted)
0.05
0.04
0.06
0.03
-
Diluted Shares Outstanding
53,739.00
53,739.00
53,739.00
53,739.00
-
EBITDA
2,612.00
458.90
2,354.30
919.30
5,555.00
Other Operating Expense
492.20
563.80
649.70
528.60
-
Non-Operating Interest Income
597.90
404.70
458.10
320.40
-

About Zenith Health Care

View Profile
Address
504, Iscon Elegance
Ahmedabad Gujarat 380051
India
Employees -
Website http://www.zenithhealthcare.com
Updated 09/14/2018
Zenith Healthcare Ltd. engages in the business of manufacturing of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. Its products include antibiotics and antiinfectives, cardiovascular system, central nervous system, gastrointestinal tract, musculo skeletal disorder, respiratory system, genito urinary system, nutrition, skin and endocrine system. The company was founded by Mahendra C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.